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It is well known that biological systems utilize communication in some form, one prolific example of this is the propagation of HIV (Human Immunodeficiency Virus) in the
human body. By modeling HIV infection as a communication system, we hope to gain a
unique insight into HIV and biological communication systems in general. Such a model
would provide researchers a platform for experimenting and simulating various biological communication systems. We have previously developed a layered communication
protocol for interpreting biological communication systems using telecommunications
paradigms and will apply said model to HIV proliferation. We will also demonstrate
the effectiveness of the model by formulating a telecommunications-based mathematical
model, and by implementing a simulation of HIV infection based on direct interpretation
of this layered protocol.
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Chapter 1
Introduction
The basis of this research was the study of communication networks at a nano-scale,
where nano-scale networks are defined as all biological or manufactured systems that exhibit some form of communication at a nano-scale. Some prolific examples of nano-scale
communication would include drug delivery and viral infection. The author previously
helped develop a layered communication protocol for interpreting biological and nanoscale communication networks[47]. This protocol was used to abstract several examples
of nano-scale communication including drug delivery for treatment of breast cancer.
The author then assisted in the development of a simulation of HIV infection by directly
interpreting the previously described layered protocol for nano-scale communication
networks (this work has recently been accepted to the Elsevier Journal of Nano Communication Networks). The results of these works demonstrated that telecommunications
paradigms can effectively be applied to study biological and nano-scale communication
networks. In this thesis, the author will further investigate the results of HIV proliferation by formulating a mathematical model based on similar mathematical models for
communication networks.
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Chapter 2
Motivation
Biological communication is an exciting new platform for Telecommunications engineers
to explore. Recent advances in biomedical technology have given birth to fields such as
gene therapy, and nano-scale drug delivery which essentially form basic methods of
communication at a biological-scale [45][41][29]. By correctly modeling and understanding the basic principles of biological communication it may eventually be possible to
engineer a complete biological communication system. The benefits provided by such a
system would be tremendous. Fields such as gene therapy, drug delivery, and cellularlevel imaging would greatly benefit from a robust engineered system. From such a
system, it would be possible to provide feedback from the nano-scale to the macro-scale,
essentially forming bi-directional communication between the macro and nano levels of
communication.
The delivery of information in a biological system can mean many things; a system which delivers anti-cancer medication is attempting to deliver information which
results in the destruction of a cancerous cell. Conversely, gene delivery vectors deliver
information encoded in DNA which attempts to repair an abnormal or mutated gene. A
biological system infected with a virus such as HIV (Human Immunodeficiency Virus) is
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simply trying to propagate information contained within the virus, albeit it does so in a
malicious manner. While the information or application delivered by a particular system
may be drastically different, the method of transportation remains similar. For instance,
most bio-communication systems employ some sort of protective capsule to protect the
information contained therein [52][32][49], resembling a sort of PDU (packet data unit).
Likewise, many such systems also contain some method of routing particles based on
physical characteristics [46][25][58], similar to any type of packet routing employed in
an electrical communication system. The similarities continue, and it is clear that there
are distinct sections of the biological system that accomplish specific goals, regardless of
their physical construction or implementation.
For these reasons we have chosen to adapt and apply our layered communication protocol [47] for biological communication to study one prolific example of such communication systems. In order to begin application of this layered communication protocol, it
is wise to start by considering a succinct system. It is also important that there is a large
body of experimental data for basis of simulation. As a result, we have chosen to apply
our layered protocol to HIV infection as it is a very well researched topic. In this manner,
we will accurately relate the communication principles of HIV proliferation into Telecommunications terminology. This protocol helps abstract the intricate processes involved
with HIV infection and lets one focus simply on the communication aspects of the system. We will use this layered protocol to develop a mathematical model and simulation
of HIV infection from a communications-based perspective. This mathematical model
will describe HIV infection based on common telecommunications-based approaches to
modeling communication networks. Our simulation will supplement this mathematical
model by demonstrating the effectiveness of the protocol and will in turn develop a
platform for experimentation and simulation of biological communication systems both
natural and synthetic.

4
A mathematical model often provides a unique insight into a complex system that a
simulation cannot. For this reason, we have chosen to expand our original focus for simulating HIV infection to include a mathematical model based on common telecommunications modeling techniques. In this paper, we shall describe existing HIV mathematical
models, formulate a telecommunications-based HIV mathematical model, and compare
and contrast the results of this model against our previous simulation. We intend to
demonstrate that our model can be used to simplify our existing simulation and provide
a different perspective on HIV proliferation.
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Chapter 3
Background
Systems which exchange information at a basic biological level have been well studied
by biologists for many years [47]. Indeed it is well known that most biological systems utilize communication in some form. While the technology to engineer a complete
communication system may currently be out of reach, the tools required to study and
experiment with bio-communication are readily available. Some of the simplest forms
of biological communication are the exchange of DNA between various organisms, in
fact DNA itself can simply be thought of as a packet or container for information. By
modeling biological systems as communication networks, one can quickly adapt various well studied Telecommunications techniques and paradigms to the system. In such
a manner, telecommunications engineers may eventually be able to develop biological
communication networks as well as electrical ones. Before this happens, it is important
to understand the basic aspects of biological communication. A layered communication
protocol is a succinct method of quickly understanding the abstracted processes involved
with communication, and can be used to efficiently understand biological communication [47]. As a result, we will adapt our previously developed protocol to a specific
example of biological communication.
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We have chosen to investigate the proliferation of HIV. Although there exist simpler
forms of biological communication, few are as well studied as HIV. For this reason, we
have applied our protocol to this specific virus. Essentially, the goal of HIV is to copy
and forward itself back into the communication channel to maximize proliferation. This
greatly resembles a multi-cast communication network in that there are many receivers
(cells) that are capable of receiving a packet (virus). The prolific amount of research in
this field will ease the process of determining constants specific to infection. Although
we have currently focused our efforts on HIV, in the future we hope to generalize this
model to account for many different types of biological communication systems.

3.1 HIV Tutorial
The propagation of HIV in the human body is a relatively straightforward process.
HIV spreads by infecting human T cells, which after being infected produce additional
viruses [43]. The end-destination for the virus is the nucleus of a target cell, where it can
change the default operation of the nucleus in order to replicate additional viruses[8][57].
In order for a virus to enter the nucleus, it must traverse the cellular pathway performing
reverse transcription, and integrating with the nucleus.
However, to infect a target cell an HIV virus must first penetrate and enter the cell.
There are two known methods with which a virus can gain entry into a cell. The first is
called fusion, where the virus fuses itself to the membrane of the cell and injects its viral
contents into the cytoplasm [10][48]. The second method involves using the Endocytic
pathway to gain entry into the cell [28][51]. Endocytosis is a process a cell uses to engulf
and eventually consume external particles. A cell performs endocytosis by forming a
vesicle around an external particle and pulling this vesicle within the cell [13]. A virus
may gain entry into a cell by escaping such a vesicle, however, if the virus fails to escape
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this vesicle it will typically be destroyed.
After the virus has gained entry into the cell it must assemble its viral genome(RNA)
into DNA. This process is referred to as reverse transcription [5]. Mutations occur frequently during reverse transcription and can often strengthen the virus to resist treatment [55]. Our research does not currently consider the effect of mutations on the viral
pathway.
Once the virus has entered the cell and the genome has undergone reverse transcription it must enter the nucleus to begin reproducing viruses, a process referred to as
integration[57]. Once a target cell’s nucleus is infected by the virus, the virus reprograms the operation of the nucleus, which starts using the cell’s resources to produce
more viruses [43]. These replicated viruses are then released into the intercellular fluids
and the process repeats itself. An infected cell may produce as many as 100 viruses per
day when it becomes productively infected[20].

8

Chapter 4
HIV Communication
4.1 Layered Protocol for Biological Communication
Previously we have described a layered communication protocol for macro to nano-scale
communication systems [47]. This protocol models the communication that takes place
when one sends a message from the macro world into the nano-world, an example of
such communication would be drug delivery. We have adapted this model for use with
generic biological communication systems, specifically how an HIV infection propagates
in a biological system. A basic diagram for HIV proliferation is shown in figure 4.1. Although HIV infection is a seemingly straightforward process, it is still necessary to split
the model amongst the various aspects of communication. For instance, when a newly
produced virus escapes an infected cell via budding, a type of routing is performed to
correctly send the virus into the plasma. This routing is considered an external process
in that it is performed at various physical structures in the system. As a result, we have
chosen to model such routing as an additional communication gateway in the system.
In such a manner, there are various layers of communication the virus must traverse in
order to be successfully received. The resultant model is similar to that of a multi-cast
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Figure 4.1: HIV Infection Pathway

communication network, where there exist many different devices which condition and
control the flow of data in the system. The layered protocol for this model is seen in
figure 4.2.

10
The flow of the protocol is somewhat straightforward. There are various junctures
in the HIV pathway where routing is performed based on characteristics of the virus.
These characteristics help form a sort of error control, which has been represented by a
transport layer. Essentially, the end goal of the virus is to switch the receiver (host cell)
into a mode of operation where it will copy and forward packets back into the channel
[36]. It is important to understand that the protocol forms a communication loop, where
the output of the receiver will attempt to forward a packet which will travel to a different
host cell. Thus we have described the complete HIV communication pathway with our
protocol, since we start and end with an application layer responsible for sending and
receiving a message.

4.1.1

Layered Protocol for HIV Infection

The layered communication protocol for this system is illustrated in figure 4.2. Many
of the processes involved in this system can be quite complex, however, they ultimately
perform a single specific function. The protocol helps one quickly understand the function of a specific phase, even if the physical or molecular implementation is not well
understood. Using this paradigm one quickly realizes how similar HIV infection is to a
multi-cast communication network. Essentially, each individual virus is a packet which
is introduced into the channel, and each target cell is a receiver which is capable of accepting such packets. At some point, with certain probability, a given cell may become
infected with a virus and begin to reproduce additional virions at a specified rate (an
infected cell is hereby referred to as a productively infected cell). At this time, the cell
switches modes of operation, and begins to not only receive packets but also to copy
and forward the received message back into the channel. A productively infected cell
has a significantly shorter lifespan than a non-infected cell as the virus quickly uses
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materials within the cell for reproduction [37]. As a result, the system suffers from the
possibility that at any point in time an infected receiver will randomly shut down. This
phenomenon is not explicitly demonstrated in the protocol but is accounted for in both
theoretical and simulation results.
The protocol itself describes the process a newly produced virus must go through
to successfully infect another cell, or in other words, how a packet must traverse the
communication network in order to be successfully received. We begin the protocol
at the stage where an infected cell produces a virus offspring, note that although the
protocol starts at this juncture the virus must somehow be introduced into the system.
More succinctly, there must be an initial broadcast of packets into the channel to begin
the communication process. After the virus is produced it must escape the host cell
which involves routing, or traversing a network layer within the cell itself. Next, the
virus must navigate the channel and arrive at a target host cell. It is possible the virus
may decay before it arrives at a host cell, however the life span of a virus is typically
much longer than the average propagation delay for a virus in the system [37]. The
arrival of the virus at the surface of the cell represents another stage of routing in the
system and is once again represented by a network layer for the communication medium.
Once a virus arrives at a target cell it must somehow be internalized in order to
infect the cell. There are several routes that the virus may take, including fusion, endocytosis, and disassociation [46][54][27]. When a virus is internalized via fusion, it simply
attaches itself to the surface of the target cell and injects its contents into the cell[27].
When considering endocytosis (endocytic pathway), the virus is engulfed by the cell for
consumption [46]. This engulfing process involves encapsulating the virus in a vesicle
within the cell. If the virus fails to escape this vesicle it is quite likely it will be destroyed [46]. Conversely, if the virus escapes the vesicle, it is capable of infecting the cell.
Lastly, if a virus disassociates from the cell, it must again attempt to enter via fusion
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or endocytosis. It is possible a virus will never correctly associate with a cell, and will
fail to deliver its message. Clearly a form of routing is performed to determine which
entry mechanism the virus must use. If the virus enters via endocytosis, there is another
protocol for routing and error control that is performed in addition to the routing at
entry.
At this point, the viral contents have been successfully internalized. Now the virus
must assemble its contents (RNA) in order to produce its message. This involves a process called reverse transcription where the RNA genome of the virus is copied into DNA
[36]. Reverse Transcription is a highly error prone process, and it is quite likely the
DNA will mutate or fail to correctly assemble into a proper message [39]. It is clear that
a form of error control is employed, in that the virus must correctly assemble its message without errors to be successfully received. The last stage of the protocol describes
how the message (DNA) must navigate to the nucleus of the cell. While the success
of this process is dependent on many factors, it essentially is another form of routing.
Once the viral DNA enters the nucleus the cell executes the viral message and begins
to replicate additional viruses. The cell must interpret and execute the message which
clearly indicates the message must be passed to the application layer of the cell. After
this point, the communication pathway is considered complete. Once a cell produces an
additional virus, the process begins once again at the application layer of the host cell.
Essentially, there is a loop formed between both application layers of the protocol, in
that this communication process is a continuous cycle.
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Figure 4.2: Layered Protocol for HIV Infection
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Chapter 5
HIV Mathematical Models
Biologists and virologists have studied HIV in depth for several decades and have formulated countless mathematical models to describe various characteristics of HIV infection.
These models range in complexity and focus and are used to describe many important
aspects of HIV proliferation both from a macro and micro level. We will review several
of these models to formulate a foundation for our model. We have chosen to describe
HIV mathematical models by classifying models into the following categories: macro
propagation - How HIV is propagated from a macro scale, i.e. how humans contact and
deliver HIV in a population; treatment propagation - How HIV propagates when being treated by some external force, such as chemotherapy; parameter estimation - How
mathematical models can be used to estimate important characteristics of HIV infection;
and micro propagation - The dynamics of HIV propagation in the human body. While
some of these categories do not directly describe the communication aspects of HIV proliferation they provide an insight as to existing rigorous methodologies for describing
specific characteristics of HIV. As a result, we feel these models can provide a basis for
out mathematical model even if they do not explicitly describe the components of HIV
proliferation we are most interested in.
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5.1 Macro HIV Propagation
Macro HIV propagation refers to the propagation of HIV from a macro standpoint, that
is, propagation in a population of HIV carriers. Such models can be useful when determining the dynamics of HIV infection in a population.

5.1.1

South African HIV Projection

Johnson et all[18] proposed a model to propagation of HIV in a South African population
of HIV carriers. The model was intended to demonstrate how the epidemic would evolve
over time and how factors such as prevention and treatment could impact the spread of
the disease[18]. Unlike other macro models, this approach considered a very specific
population and incorporated sample data specific to the population [18].
The authors came out with the following set of equations which help model the
propagation of HIV in a South African population:
The parameter Ttij (y) is defined to be the probability that an HIV-positive y-year old
female, in stage t of the disease and in risk group j, transmits the virus to a partner in
risk group i in a single act of sex. The parameter is calculated as follows[18]:

Ttij (y) = rij ∗ It (1 − [1 − (1 − c j (y)) Rt ]e)

(5.1)

Where
1. rij is the average probability of transmission from an HIV-positive female in risk
group j to an HIV-negative male in risk group i, in a single act of unprotected sex.
2. It is the factor by which rij is multiplied if the HIV-positive female is in stage t of
disease (see figure 5.1).
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3. c j (y) is the probability that a sero-discordant couple use a condom when the index
partner is aged y and in risk group j.
4. Rt is the factor by which the proportion that are unprotected is multiplied in stage
t of disease (see figure 5.1) (taking into account the effect of knowledge of HIV
status).
5. e is the probability that a condom is effective in preventing HIV transmission in a
single act of sex.
∗ ( y ) with parameters r ∗ , R∗ is also considered for males,
An identical formula Ttij
t
ij

which replaces Ttij , rij , and Rt which maple-specific parameters.
The probability of HIV infection is then calculated as[18]:
59

4

1 − 1 − a( x ) ∑ wij
j =1

∑

y=14

6

f ( x |y) ∑

∗
∗
ptj (y)[1 − (1 − Ttij
(y))nij Sy Dt ]

Pi Sx

(5.2)

t =1

Where
1. a( x ) is the factor by which the per-partners transmission probability is multiplied
in women aged x.
2. wij is the proportion of male partners who are in risk group j.
3. ptj (y) is the proportion of male partners (aged y and in risk group j) who are
HIV-positive and in stage t of the disease.
4. nij is the number of coital acts per partnership between a female in risk group i
and a male i risk group j.
5. Dt is the factor by which the coital frequency is multiplied in stage t of the disease.
6. Pi is the average annual number of partners for a woman in group i
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The author’s then compared their model against measured data for prevalence of
HIV in the South African populace and found that their model aligned very well with
measured results, see Figure 5.2.

5.1.2

Estimating Viral Infectiousness in a population

Wilson et all described a mathematical model for estimating if an individual carrying
HIV with a certain infection rate was capable of infecting others. Specifically, the authors
wanted to determine if a viral load of less than 10 HIV RNA copies per mL plasma could
infect other individuals, and if so what the associated risk would be [60].
The authors derived an equation for the transmission probability of HIV infection
using the data from a previous study by Rakai et all. This equation states that each
ten-fold increment in viral load is associated with a 2 ∗ 45 fold increase in the risk of HIV
infection[60]:

β 1 = 2 ∗ 45log10 (V1 /V0 ) β 0

(5.3)

Where
1. β 0 - Probability of HIV transmission from a person with a baseline viral load V0
2. β 1 - Probability of transmission probability corresponding to any other viral load
V1
The authors then found the cumulative risk of obtaining HIV from n exposures to be
as follows:

1 − (1 − β + 1) n

(5.4)
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The authors obtained results from their model which demonstrates the transmission
probability, as well as the cumulative transmission probability of an HIV transmission
after a given number of sexual exposures, see Figure 5.3.

5.2 Treatment Propagation
Treatment propagation refers to the propagation of HIV when under an external treatment force. This force can be radiation, medicine, or any number of potential treatment
programs. These models are extremely useful to those researchers studying HIV treatment and can help determine which aspects of HIV propagation are most susceptible to
therapy.

5.2.1

HIV-1 pathogenesis with delay (antiretroviral therapy)

Nelson et all described a mathematical model for assessing the viral decay of HIV-1 in
patients receiving antiretroviral therapy[33]. The authors demonstrate that many similar
treatment-based mathematical models fail to consider important aspects of drug-based
treatment and consider the treatment to be more or less perfect [33]. As a result, the
authors considered the effect of a less than perfect treatment, where the efficacy of the
drug may be less than 100%.
The authors derived their model from the general form of the non-delay model,
which is found as follows [33]:
dT
= λ − δ1 T − kV1 T
dt

(5.5)

dT ∗
= kV1 T − δT ∗
dt

(5.6)
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dV1
= (1 − n p ) NδT ∗ − cV1
dt

(5.7)

dVN I
= n p NδT ∗ − cVN I
dt

(5.8)

Where
1. T - Uninfected T cells
2. T ∗ - Infected T cells
3. VI - Infectious virus
4. VN I - Noninfectious virus
5. δ - Decay rate of virus producing T cells
6. c - Viral clearance constant
7. n p - Drug efficacy of protease inhibitor
The authors then introduced an intercellular delay into the model as follows [33]:
dT ∗
= dT0 V1 (t − τ )e−mτ − δT ∗
dt

(5.9)

dV1
= (1 − n p ) NδT ∗ − cV1
dt

(5.10)

dVN I
= n p NδT ∗ − cVN I
dt

(5.11)

The eigenvalues of the above equations can be used to determine the rate of viral
decline for the model [33]. Extracting these eigenvalues is not a trivial task; a thorough
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proof of this can be found in [33]. The result is that the rate of viral decay µ̃ is approximately:

µ̃ ∼ −

δn p
= −δn p C (τ, n p , δ)
1 + (1 − n p )δτ

C (τ, n p , δ) =

1
<1
1 + (1 − n p )δtau

(5.12)

(5.13)

Thus by assuming a constant intercellular delay the decay rate of virus producing T
cells δ is estimated as

δ∼

slope
npC

(5.14)

Which indicates that the viral decay in HIV patients under antiretroviral therapy was
dependent on δ, n p , and τ, which are the decay rate of viral producing cells, the efficacy
of treatment, and the intercellular delay.

5.2.2

HIV Chemotherapy Treatment

Kirschner et all proposed a mathematical model to study the effect of chemotherapy
treatment of HIV infection [23]. The authors used clinical data to fit their model to
match the turnover rates and the life spans for sample populations [23].
The authors present the following equations for their model, where T (t) is the uninfected T cell population (at time t), Ts (t) is the drug-sensitive infected T cell population
(at time t), Tr (t) represents the drug resistant T cells (at time t), Vs (t) is the drug-sensitive
virus population (at time t), and Vr (t) is the drug-resistive virus population (at time t).
These populations are all assumed to be measured in blood plasma. The mathematical
model without considering treatment is give as [23]:

21

T 0 (t) = S(t) − µt T (t) +

pT (t)Vs (t)
− k s Vs (t) T (t)
C + Vs (t)

Ts0 (t) = k s Vs (t) T (t) − µ Ti Ts (t) −

Vs0 (t) = N pi Ts (t)

pi Ts (t)Vs (t)
Ci + Vs (t)

Vs (t)
Gs Vs (t)
− k v T (t)Vs (t) +
Ci + Vs (t)
B + Vs (t)

S(t) = 10 − 7

V (t)
Bs + V (t)

Where
1. µ T is the mortality rate of uninfected T cells
2. µ Ti is the mortality rate of infected T cells
3. k s is the rate T cells are infected by drug-sensitive viruses
4. kr is the rate T cells are infected by drug-resistant viruses
5. k v is the rate T cells kill the virus
6. p is the proliferation rate of uninfected T cells
7. pi is the proliferation rate of infected T cells
8. Gs is the rate of input of drug-sensitive viruses to the bloodstream
9. Gr is the rate of input of drug-resistive viruses to the bloodstream
10. q is the probability of mutation
11. N is the number of viable viruses produced in bursting

(5.15)

(5.16)

(5.17)

(5.18)
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12. C is the half-saturation constant of uninfected T cells
13. Ci is the half-saturation constant of infected T cells
14. B is the half-saturation constant of external virus input
15. Bi is the half-saturation constant of constant T cell source
16. µ treatment parameter
17. η treatment parameter
18. ρ treatment parameter
The authors then expanded this model to account for chemotherapy treatment of HIV
as follows:

T 0 ( t ) = S0 ( t ) − µ T T ( t ) +

pT (t)V (t)
− (µk s Vs (t) + kr Vr (t)) T (t)
C + V (t)

Ts0 = µk s Vs (t) T (t) − µ Ti Ts (t) −

Tr0 (t) = kr Vr T (t) − µ Ti Tr (t) −

Vs0 (t) =

Vr0 (t) =

pi Ts (t)V (t)
Ci + V (t)
pi Tr (t)V (t)
Ci + V (t)

(5.19)

(5.20)

(5.21)

ρq(t) N pi Ts (t)V (t) (1 − q(t)) N pi Tr (t)V (t)
Gs Vs (t)
+
− k v T (t)Vs (t) + η
(5.22)
Ci + V (t)
Ci + V (t)
B + V (t)

q(t) N pi Tr (t)V (t) (1 − q(t)) N pi Ts (t)V (t)
Gr Vr (t)
+
− k v T (t)Vr (t) +
Ci + V (t)
Ci + V (t)
B + V (T )

(5.23)
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The premise of this treatment model explains the inhibition of HIV as similar to
reverse transcriptase inhibitor [23]. Figure 5.5 shows a simulation based on this model
which shows the effect of treatment on the progression of HIV, where the dashed line is
non-treatment.

5.2.3

Structured Treatment Interruptions

Adams et all presented a mathematical model used to study how to best model the
structured treatment interruptions (STI) [2]. In this case, STI refers to the process of
allowing a patient’s immune system to regain its ability to fight the viral infection [2].
This means that rather than attempt to completely eradicate the virus, treatment should
instead focus on trying to suppress it. Numerous methods of STI have been proposed,
many of which assess changes in the HIV immune response [2]. As a result, the authors
have suggested a mathematical model which incorporates an STI-based methodology.
The model is based upon the Callaway-Perelson model and can be described as follows:

Ṫ1 = λ1 − d1 T1 − (1 − e)k1 VT1

(5.24)

Ṫ2 = λ2 − d2 T2 − (1 − f e)k2 VT2

(5.25)

T˙1∗ = (1 − e)k1 VT1 − δT1∗ − m1 ET1∗

(5.26)

T˙2∗ = (1 − f e)k2 VT2 − δT2∗ − m2 ET2∗

(5.27)

V̇ = NT δ( T1∗ + T2∗ ) − cV − [(1 − e) p1 k1 T1 + (1 − f e) p2 k2 T2 ]V

(5.28)
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Ė = λ E +

bE ( T1∗ + T2∗
d E ( T1∗ + T2∗
E
−
− δE E
( T1∗ + T2∗ ) + Kb
( T1∗ + T2∗ ) + Kd

(5.29)

Where Ṫ1 is a type 1 target, Ṫ2 is a type 2 target, T˙1∗ is a type 1 infected target, T˙2∗ is a
type 2 infected target, V̇ are free virions, and Ė are immune effectors [2].
1. λ1 target cell type 1 production rate
2. d1 target cell type 1 death rate
3. e population 1 treatment efficacy
4. k1 population 1 infection rate
5. λ2 target cell type 2 production rate
6. d2 target cell type 2 death rate
7. f treatment efficacy reduction in population 2
8. k2 population 2 infection rate
9. δ infected cell death rate
10. m1 immune-induced clearance rate for population 1
11. m2 immune-induced clearance rate for population 2
12. NT virions produced per infected cell
13. c virus natural death
14. p1 average number of virions infecting type 1 cell
15. p2 average number of virions infecting type 2 cell
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16. λ E immune effector production rate
17. bE maximum birth rate for immune effectors
18. Kb saturation constant for immune effector birth
19. d E maximum death rate for immune effectors
20. Kd saturation constant for immune effector death
21. δE natural death rate for immune effectors
The authors then presented simulation results which show the virus propagation
over time, see figure 5.6.

5.2.4

Antiretroviral Therapy for Low Viral Loads

Wein et all presented a mathematical model to investigate which factors are most critical for ensuring successful antiretroviral therapy to eliminate HIV-1. [59]. The model
is derived from a standard model for HIV proliferation created by Perelson et al [40],
but is generalized to introduce two drug-sensitive and drug-resistant viruses, protease
inhibitors that are not 100% effective, and incorporates dynamics of uninfected cell populations [59].
The model can be described through figure 5.7, which shows a system diagram of the
model [59]. Where A virus V, infects a T cell, T, with rate k and generates productively
infected T cells T ∗ . Additionally the virus infects long-lived cells, M, with rate k M and
produces productively long-lived T cells M∗ . Productively infected T cells die at rate δ
and produce N virions before death. Similarly, productively infected long-lived cells die
at rate δ M and produce N M virions before death.
This model may be more rigorously defined as a system of equations, given as:
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T (t) = s + λT (t)(1 −

T (t) + T1∗ (t) + T2∗ (t)
) − µT (t) − k1 (1 − r1 ) T (t)V1I (t) − k2 (1 − r2 ) T (t)V2I (t)
Tmax
(5.30)

T1∗ (t) = m11 k1 (1 − r1 ) T (t)V1I (t) + m21 k2 (1 − r2 ) T (t)V2I (t) − δ1 T1∗ (t)

(5.31)

T2∗ (t) = m22 k2 (1 − r2 ) T (t)V2I (t) + m12 k1 (1 − r1 ) T (t)V1I (t) − δ2 T2∗ (t)

(5.32)

M(t) = λ M − µ M M (t) − k1M (1 − r1 ) M (t)V1I (t) − k2M (1 − r2 ) M(t)V2I (t)

(5.33)

M1∗ (t) = m11 k1M (1 − r1 ) M(t)V1I (t) + m21 k2M (1 − r2 ) M(t)V2I (t) − δ1M M1∗ (t)

(5.34)

M2∗ (t) = m22 k2M (1 − r2 ) M(t)V2I (t) + m12 k1M (1 − r1 ) M(t)V1I (t) − δ2M M2∗ (t)

(5.35)

V1I (t) = (1 − p1 ) N1 δ1 T1∗ (t) + (1 − p1 ) N1M δ1M M1∗ (t) − c1 V1I (t)

(5.36)

V2I (t) = (1 − p2 ) N2 δ2 T2∗ (t) + (1 − p2 ) N2M δ2M M2∗ (t) − c2 V2I (t)

(5.37)
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V1 (t) = N1 δ1 T1∗ (t) + N1M δ1M M1∗ (t) − c1 V1 (t)

(5.38)

V2 (t) = N2 δ2 T2∗ (t) + N2M δ2M M2∗ (t) − c2 V2 (t)

(5.39)

Where
1. T is the number of uninfected T cells
2. T1∗ is the number of T cells infected by virus strain 1 (V1I V1 , drug-sensitive virus)
3. T2∗ is the number of T cells infected by virus strain 2 (V2I V1 , drug-resistive virus)
4. M is the number of uninfected macrophages (long-lived cells)
5. M1∗ is the number of macrophages infected by virus strain 1
6. M2∗ is the number of macrophages infected by virus strain 2
7. V1I V1 is the number of viruses of strain 1
8. V2I V2 is the number of viruses of strain 2
1. s is the rate of supply of uninfected T cells
2. λ is the maximum growth rate of uninfected T cells
3. Tmax is the maximum number of uninfected T cells
4. µ is the death rate of uninfected T cells
5. δ1 δ2 are the loss rates of infected T cells
6. k1 k2 is the infectivity rates of the virus
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7. N1 is the burst size of strain 1
8. N2 is the burst size of strain 2
9. c1 , c2 is the death rates of the virus
10. m12 , m21 are the mutation probabilities
11. λ M is the production rate of uninfected macrophages
12. µ M is the death rate of uninfected macrophages
13. δ1M δ2M are the loss rates of infected macrophages
14. k1M k2M are the infectivity rates of the virus (in macrophages)
15. N1M is the burst size of strain 1 from macrophages
16. N2M is the burst size of strain 2 from macrophages
The authors used their model to predict the viral load and T cell count when a patient
underwent induction therapy before switching to mainenance therapy at 9 months (solid
line) or terminated therapy (dashed-line), see Figure 5.8. Induction therapy as it applies
to HIV infection, is the initial treatment process used to rapidly reduce the number of
viruses in the body to below some threshold [42]. However, such treatment is very
harsh to the patient and is difficult to sustain for long-term treatment [59]. As a result,
induction therapy is often followed by maintenance therapy. Maintenance therapy is a
treatment process used to sustain the initial treatment, but is not as caustic to the patient
[15].
The simulation assumed that the patient switched from induction therapy to maintenance therapy at 9 months or discontinued maintenance therapy altogether [59]. The
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authors indicate that had the patient maintained induction therapy regiment the virus
would have been eradicated [59].

5.3 Parameter Estimation
Parameter estimation refers to estimating various aspects of HIV proliferation. These
estimates can help determine important details of HIV proliferation that can supplement
other mathematical models, or simply provide insight into HIV dynamics.
Banks et all provided a model for determining which parameters of HIV infection
models are most influential in the outcome of a given model [6]. The authors examined
existing models of HIV proliferation and using sensitivity analysis sought to determine
the impact specific parameters have on the model [6]. This technique is advantageous
in that many times a researcher cannot always easily describe the specific relationship a
given parameter has on the outcome of their model.
The author’s technique for determining sensitivity equations involved taking derivatives of equations with respect to the parameter of interest to find a new system of
equations which demonstrate more clearly how a given variable affects the model [6].
Determining the sensitivity equation can be a very challenging task; the authors provide
a detailed explanation of their methodology in [6].
To demonstrate how their model could be used the authors determined which parameters most influenced a specific equation in a given mathematical model of HIV
proliferation [6]. The authors were able to detail which parameters were most influential
in the growth of this model.
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5.4 Micro Propagation
Micro propagation refers to describing the in vivo interactions of HIV. Such models are
most applicable to our model and as such will form the foundation for any models we
describe. Micro propagation is largely concerned with estimating the ”state” of the human body under HIV infection. In other words, describing how properties such as the
number of viruses or T cells change or can affected by various aspects of infection. These
are exactly the type of properties that are most important in our formulation of a mathematical mode, and as such we will focus largely on these types of HIV models. Micro
models can be broken into several standard approaches which include: The standard
model, delay model, combination therapy and delay [34]. Many of the basis for models
presented in section 5.1 and 5.2 can be explained by one of these micro propagation
models.

5.4.1

Standard Model

The standard model provides a quintessetial relationship which describes the concentration of virions in plasma as well as the number of T cells. Many models for HIV propagation use this basic identity to describe virus and T cell growth [38]. In this model,
the relationship between the concentration of virions in plasma, V, and the number of
infected T cells, T ∗ , is described through the following equations:
dT ∗
= kVT − δT ∗
dt

(5.40)

dV
= NδT ∗ − cV
dt

(5.41)

Where T is the number of uninfected T cells, δ is the rate of loss of infected cells, N
is the number of new virions produced per infected cell (during its lifetime), and c is
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the rate constant for viral clearance. If one were to use this system of equations alone,
then by assuming a constant T cell count for the initial phase of infection and assuming
that the number of infected T cells increases linearly, it is trivial to determine the viral
concentration. Experimental evidence supports the fact that during the initial infection
phase the total number of T cells will remain constant [36]. This simplification of the
model eases the calculation of virus and T cell growth.
The model can be further expanded to model the effect of treatment on the system,
this is given as follows [34]:
dT ∗
= kT0 VI − δT ∗
dt

(5.42)

dVI
= (1 − n p ) NδT ∗ − cVI
dt

(5.43)

dVN I
= n p NδT ∗ − cVN I
dt

(5.44)

Where
1. T0 is the constant level of target cells
2. n p is the efficacy of the protease inhibitor
3. VN I is a non-infective virus (as rendered by treatment)
4. nrt is the effectiveness of the reverse transcriptase inhibitor

5.4.2

Delay Model

The standard model can be generalized to account for the delay of viruses introduced
into a system and the time until the production of new viruses begins [34].
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The model expands on the standard model as follows [34]:
dT ∗
= (1 − nrt )kT0
dt

Z ∞
0

f (τ )VI (t − τ )e−mτ dτ

(5.45)

dVI
= (1 − n p ) NδT ∗ − cVI
dt

(5.46)

dVN I
= n p NδT ∗ − cVN I
dt

(5.47)

f (τ ) = gn,b (τ ) ≡

τ n −1
e−τ/b
(n − 1)!bn

(5.48)

The delay is given by a constant τ, and the term e−mτ accounts for cells that are
infected at time t but die before they begin producing additional viruses [34]. The delay
distribution f (τ ) was chosen to be a gamma distribution where the mean delay sets the
location of the delay, and n sets the width of the distribution [34].

5.4.3

Combination Therapy and Delay

The combination therapy model suggests that long-term HIV patients have a relatively
constant viral count in their plasma [38]. This model accounts for this dynamic by
introducing the following relationship:
d
dT ∗
= (VI + VN I ) = 0
dt
dt

(5.49)

When therapy is first considered, the patient is given a non-infectious viral count of
VN I = 0 and at some time t > 0 the patient’s system starts to be affected by the treatment
[34].
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5.4.4

HIV Dynamic Model

Wu et all proposed a dynamic model for HIV propagation that considers a simple sum
of exponentials to model the progression of HIV [61]. The model was constructed to
be simple, yet robust enough to realistically model HIV proliferation, is based on a nonlinear mixed effect model [61].
The model is given by the following equations:
d
Tm = (1 − γ)αm k0 TVI − δm Tm − µm Tm
dt

(5.50)

d
Ts = (1 − γ)αs k0 TVI − δs Ts − µs Ts
dt

(5.51)

d
T = (1 − γ)αl k0 TVI − δl Tl − µl Tl
dt l

(5.52)

d
Tp = (1 − γ)α p k0 TVI − δp Tp − µ p Tp
dt

(5.53)

d
VI = (1 − η ) P − cVI
dt

(5.54)

d
VN I = ηP + Nδm Tm + Nδs Ts + Nδp Tp − cVN I
dt

(5.55)

Where
1. T is an uninfected T cell
2. Tm infected cells other than T cells
3. Ts long-lived infected cells
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4. Tl cells that are infected but are latent in producing viruses
5. Tp productively infected cells
6. VI infectious virus
7. VN I non-infectious virus
8. dl rate at which Tl becomes productively infected
9. dm rate at which Tm becomes productively infected
10. ds rate at which Ts becomes productively infected
11. d p rate at which Tp becomes productively infected
12. µm rate at which Tm dies
13. µs rate at which Ts dies
14. µl rate at which Tl dies
15. η proportion of non-infectious viruses produced by infected cells
16. c ellimination rates of viruses
17. k infection rate
18. αm proportion of cells which are Tm
19. αs proportion of cells which are Ts
20. αl proportion of cells which are Tl
21. α p proportion of cells which are Tp
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The final equation for the model is then given by:

V (t) = P0 + P1 e−λ1 t + P2 e−λ2 t + P3 e−λ3 t + P4 e−λ4 t + P5 e−λ5 t + P6 e−λ6 t + P7 e−λ7 t + P8 e−λ8 t
(5.56)
Where
1. Pi |i = 0, ..., 8 are functions of the parameters in equations that represent the initial
viral production rate 5.50 through 5.55
2. λ1 = δp
3. λ2 = δm + µm
4. λ3 = δs + µs
5. λ4 = δl + µl
6. λ5 = c
7. λ6 = r
8. λ7 = c + r
Although the derivation of the final model is a little involved, the end result is relatively simple and does not require solving a complex series of equations to model the
growth of viruses. The authors were able to further simplify their model by ignoring
those cells which do not greatly affect the overall virus growth, the model is given as
follows [61]:

V (t) = P0 + P1 e−δp t + ( P2 + P3 t)e−ct

(5.57)
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A simulation demonstrating the effective rate of growth as calculated by the author’s
model and compared to measured patient data can be seen in figure 5.9.
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Figure 5.1: Model of HIV disease progression in adults[18]
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Figure 5.2: HIV prevalence of women attending public antenatal clinics[18]

Figure 5.3: Relationship between transmission probability per act and viral load[60]
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Figure 5.4: Cumulative risk of HIV tranmission vs number of sexual exposures[60]

Figure 5.5: T cell count (A) and viral titer (B)[23]
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Figure 5.6: Simulation of early infection scenario[2]
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Figure 5.7: System Diagram of Model[59]
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Figure 5.8: Model and Induction Therapy Results[59]

Figure 5.9: Comparison of Simulated and Measured HIV-1 RNA copies[61]

43

Chapter 6
Telecommunications-based
Mathematical Model
It is clear from section the previous section that current HIV mathematical models are
extremely diverse, in terms of their focus, complexity, and methodologies. In contrast
to these existing methods, we propose a mathematical model of HIV from a telecommunications perspective. Instead of concerning ourselves with the biological interpretation
of these processes, we aim simply to describe HIV in the context of a communication
pathway. We will rely on existing methodologies of modeling communications networks
to describe HIV proliferation. We believe our approach will be quite simple in comparison to many of the aforementioned HIV models, and might give researchers a new
perspective on methods with which they could model HIV infection.

6.1 Queuing Networks
In a typical multi-node communication network, packets are sent and routed through
many machines where they are buffered, processed and forwarded to their appropriate
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destination. Often, this process can cause packets to become stacked or queued in a
specific machine that must process them. As a result, queuing theory has proven very
insightful in telecommunications modeling, as a node in a network can be simply and
effectively modeled using a queue. We will now explain some of the basic concepts
behind queuing theory.

6.1.1

Exponential Distribution and Poisson Process

The exponential distribution and Poisson process are essentially the foundation for rigorously describing a queue.
A continuous random variable X has an exponential distribution with parameter
λ|λ ≥ 0 if its probability density function is given as follows[44]:
f ( x ) = λe−λx | x ≥ 0, 0 otherwise

(6.1)

An important characteristic of the exponential distribution is that it is a memoryless
distribution, formally stated as follows for a random variable X with parameter x, t > 0
[3]:

P( X > x + t| X > t) = P( X > x ) = e−µx

(6.2)

This property becomes extremely important when considering waitings times in a
queue, as the probability of a new arrival is in no way influenced by previous arrivals in
the queue [3].
Building upon the exponential distribution, a Poisson process is a counting process if
N(t) represents the number of arrivals that have occured in the interval (0, t) [56]. Formally this can be described as follows[44]:
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The counting process N (t), t ≥ 0, is a Poisson process with rate λ ≥ 0 if
1. N(0) = 0
2. The process has independent increments
3. The number of events in any interval of length t is Poisson distributed with mean
λt. That is ∀ x, s ≥ 0
P( N (t + s) − N (s) = n) = e−λt

(λt)n
n! ,

n = 0, 1, 2, ...

Two important properties of the Poisson process are the merging and splitting properties.
The merging property states that if N1 (t) and N2 (t) are two independent Poisson
processes with rates λ1 and λ2 respectively, then the sum N1 (t) + N2 (t) is also a Poisson
process with rate λ1 + λ2 [3].
The splitting property states that if N(t) is a Poisson process with rate λ and each
arrival is marked with a probability p, that is independent of all other arrivals. Then if
we denote N1 (t) and N2 (t) as the number of marked and unmarked arrivals respectively,
then N1 (t) and N2 (t) are both Poisson processes with rate λp and λ(1 − p) respectively
[3].
This properties will again play a critical role in defining and understanding queues.

6.1.2

Basic Queue Model

The basic queuing model can be seen in Figure 6.1. The queue consists of a constant
input of ”customers” (although customers can mean many things), who are waiting to
be processed by a ”server.” Customers arrive in the queue at a given rate and wait to be
served. A queuing model must address the following properties[3]:
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Figure 6.1: Basic Queue Model[3]

1. The arrival of ”customers.” Often customers in a queue arrive according to a Poisson process.
2. The behavior of customers. In a generic queue customers are free to leave the
queue or stay in the queue.
3. The service times. Service times are often modeled using an exponential distribution.
4. The service discipline. The server may choose to serve a certain number of customers, or serve customers in a certain order.
5. The service capacity. The queue may allow multiple servers to process customers.
6. The waiting room. The queue may have limited resources and can only allow a
certain number of customers to wait.
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Queues are often classified into groups by their arrival distribution, the distribution
of their waiting time, and the number of servers in the queue [3]. Thus a queue can
be referred to using Kendall notation, where the notation is a/b/c. ’a’ refers to the
arrival distribution of customers (M denotes exponential arrival), ’b’ refers to the service
distribution (M denotes exponential as well), and ’c’ denotes the number of servers in
the queue[3].

6.1.3

M/M/1 Queue

The M/M/1 queue is one of the most prolific types of queues, this is largely due to
its simplicity (both to model and analyze) and ability to realistically model real-world
examples of queues [17].
As previously mentioned an M/M/1 queues has an exponential customer arrival rate
λ, an exponential service rate µ, and possesses a single server[3]. An important property
of the queue that must be observed is the fraction of working time for the server, or ρ.

ρ=

λ
<1
µ

(6.3)

Without this constraint analysis of the server would queue would produce non-real
results.
There are several important properties of the M/M/1 queue that one would wish to
analyze. First, the mean number of customers in the queue can be calculated using the
following equation [3]:
∞

E( L) =

ρ

∑ np + n = 1 − ρ

(6.4)

n =0

Also, we may wish to find the mean time a customer spends in the queue. To accomplish this we need a property called ”Little’s Law”, which states simply the following
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Figure 6.2: Two-Stage Queuing Network

[17]:

E( L) = λE(S)

(6.5)

Using Little’s law we find that the mean time spent by a customer in the queue is as
follows:

E(S) =

1/µ
1−ρ

(6.6)

As evident, the simple nature of the queue makes analysis of these properties a
straightforward process.

6.1.4

Networks of Queues

A network of queues is defined simply as a system where a series of queues route
customers between queues. This routing can be random or dependent on some other
property of the queuing network. A queuing network can be used to realistically model
a complex system of interconneted nodes, and is often used to effectively model communication networks.
Consider once again the basic queue model as previously defined. A two-stage queuing network is a network which consists of two basic queues connected in tandem, see
Figure 6.2[62]. The network consists of two simple queues with service rates µ0 and
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µ1 , where the external arrival of customers to the network is a Poisson process with
rateλ. Interestingly, the arrival of customers to queue 1 is also a Poisson process, this is
explained by Burke’s Theorem (a proof of Burke’s theorem is outside the scope of this
paper, see [62] for a detailed proof). In fact the arrival rate to the second queue is also λ.
In order to analyze queuing networks and derive important characteristics it is necessary to analyze the queue using Jackson’s Theorem for Open Queuing Networks. An
open queuing network is defined as a queuing network where customers enter and leave
the network, this is in contrast to a closed queuing network where customers neither enter nor leave the network[62]. Jackson’s theorem assumes the following characteristics
[62]:
1. The network is composed entirely of K first-come first-serve, single server queues
2. The arrival for all K queues is Poisson with rate r1 ,...,rK
3. The service times of customers in the jth queue is exponential with mean 1/µ j
4. When a customer leaves a queue i, it enters another queue j with probability Pij or
it leaves the system with probability 1 − ∑Kj=1 Pij . Where Pij is the probability that
a customer will be routed from queue i to queue j.
Thus, in a Jackson queuing network the arrival rate for each queue is given by the
following equation, where the arrival is Poisson[62]:
K

λ j = r j + ∑ λi Pij , j = 1, ..., K

(6.7)

i =1

It follows that the utilization factor of each queue is then given by the equation[62]:

ρ = λ j /µ j , j = 1, ..., K

(6.8)
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Jackson’s theorem is then stated as follows and assumes that ρ j < 1, and Ni is state
of the ith queue[62]:

P( N1 ...NK ) = P1 ( N1 ) P2 ( N2 )...PK ( NK )

(6.9)

Where

Nj

Pj ( Nj ) = ρ j (1 − ρ j ), Nj ≥ 0

(6.10)

Jackson’s theorem greatly simplifies the analysis of queuing networks, since one can
more easily study specific queues in the network.

6.2 Queuing Networks for Communication Systems
Queuing networks have been extensively used to study and model computer networks
[14][19]. Such queuing models are used to simulate and account for the limited capacity
of networks and often use standard queuing models such as the M/M/1 queue [14].
Such models have been shown to accurately predict network performance and are often
the primary tool used to evaluate telecommunications networks [19][16].

6.2.1

Bluetooth Queuing Model

Kibria et all developed a queuing model to analyze multipoint Bluetooth connection
systems[22]. The model was designed to study ah-hoc Bluetooth networks and demonstrates how a queueing model can be used to understand performance in terms of efficiency and correctness of data transfers in such an environment [22]. The queuing model
used priority queues to categorize Bluetooth devices according to several parameters[22].
The queuing model for this system uses a priority queue of type M/G/1, with one
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Bluetooth device as the acting master and several Bluetooth devides acting as slaves.
The M/G/1 queue is similar to the M/M/1 queue but is generalized to account for an
arbitrary distribution for service times[12]. The generalized service time distribution
of the queue allows one to fit the model more precisely to the system of interest. As
jobs (devices) arrive in the system they are queued according to their priority groups
[22]. These priority queues were categorized by the following parameters: bandwidth,
delay, delay variation, throughput, and packet loss [22]. By categorizing Bluetooth users
according to these parameters the master is able to utilize its resources more efficiently
as it can more accurately determine how to interact with the slave devices [22]. Figure
6.3 shows an overview of the queueing model for this system.
The QoS for this system can be derived from the queueing model. The QoS will
be determined in terms of the utilization factor ρ, and the mean service time X̃. The
utilization factor for a job p with arrival rate λ p and mean service time X˜p is defined as
follows[22]:

ρ p = λ p X˜p

(6.11)

We now denote the delay or wait time for a specific priority p as Wp , and define the
average wait time for the queue as W0 . It follows that Wp is derived as follows[22]:
P

Wp = W0 +

∑

i= p

X̃i λi Wi +

P

∑

X̃i λi Wp

(6.12)

i = p +1

The throughput, denote β is then defined as the multiplication of the average arrival
rate (λ) with the packet size to be sent [22]. It then follows that the packet loss can be
calculated as follows:

β Packetloss = TotalDataToSend − DataBeingSent

(6.13)
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Figure 6.3: Bluetooth Queuing Model[22]

Using these equations the authors were then able to derive the optimal throughput
of a given Bluetooth network.

6.2.2

Ad Hoc WLAN Queuing Model

Özdemir el all developed a queueing model to study the performance of the IEEE 802.11
MAC protocol for wireless LAN [35]. The author’s model is based on the M/G/1/k
queueing model. An M/G/1/k queue is an M/G/1 queue with a finite buffer size,
namely k [31]. This model often describes a queue more realistically as a queue typically
cannot be infinite in length.
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The system model is comprised of three entities which include the back-off algorithm,
the service time distribution, and the queueing model itself[35]. Back-off algorithms are
commonly used within communication networks to avoid collisions and network congestion when transmitting data[7]. This model describes the entire 802.11 MAC protocol
and is outlined as follows[35]:
1. Initialize B0 (the steady-state probability that a node is busy or non-empty) and the
probabilities that a node is in any of the m + 1 back-off stages.
2. Calculate the collision probabilities ci for each back-off stage and the corresponding
transmission attempt probability τ.
3. Given ci and τ evaluate the packet service rate µ.
4. Given µ and λ find all the state probabilities in M/G/1/k queueing system.
5. Repeat 2, 3, 4 until the difference between a new and previous value for b0 is
arbitrary.
A diagram of this system may be seen in Figure 6.4. Although the authors modeled
and described their model of the back-off algorithm, it is outside the scope of this paper,
see [35] for details.
The author’s queueing model is based on the M/G/1/K model, with the following
parameters λ as the packet arrival rate, B(x) as the distribution of the packet service time,
b as the expected value of the packet service time[35]. The throughput of the system (γ)
is then defined as follows[35], where Pk is the time average of finding k packets in the
system:

γ = λ(1 − PK )

(6.14)
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Figure 6.4: IEEE 802.11 Organization Model[35]
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and the traffic intensity ρ is defined as:

ρ = λb =

λ
µ

(6.15)

From [12] and [50] it is shown that PK can be evaluated in terms of the steady state
probabilities as follows:

Pk =

πk
π0 + ρ

PK = 1 −

1
π0 + ρ

(6.16)

(6.17)

Using these equations the authors derived the average packet delay and the throughput of the system. The packet delay E[ T ] can be found in terms of the average number
of packets in the system, E[l ] as follows[35]:
∑kK=−11 kπk
1
E[ L] = ∑ kPk =
+ K (1 −
π0 + ρ
π0 + ρ
k =1
K

(6.18)

then using Little’s Law the packet delay is found as[35]:

E[ T ] =

1 K −1
kπk + K (π0 + ρ − 1)]
[
λ k∑
=1

(6.19)

Equation 6.14 can then be modified to find the throughput accounting for packet
collisions. The throughput if a packet collides m times is then given as follows, where
ci,n is the probability of collision given stage i and n busy nodes:

Γn =

m
λ
(1 − ∏ ci,n )
π0 + ρ
i =0

(6.20)
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Figure 6.5: WLAN Queue Model vs Simulation - Packet Delay

Γ=

N

∑ Γn β n

(6.21)

n =1

The authors then compared their model against simulation results and found their
analysis tracked the expected results quite closely, see Figure 6.5, 6.6.

57

Figure 6.6: WLAN Queue Model vs Simulation - Throughput
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Figure 6.7: HIV Cellular Pathway Queuing Network

6.3 HIV Queuing Theory Model
Following the example of telecommunications-centered queuing networks, we have chosen to model the proliferation of HIV as a queuing network. We consider each cell in
the system to consist of a queuing network, where customers are viruses and servers
are mechanisms in the cellular pathway. Each queue is treated as an M/M/1 queue to
simplify the analysis of the network. The result is that each cell in our model forms an
open queuing network, see Figure 6.7.
The states in the cell are derived from our layered protocol for HIV proliferation
(as seen in Figure 4.2) and are as follows: cell surface, vesicle (endocytosis), cytoplasm,
nucleus. Where each state is fed viruses by a queue in the network consisting of each of
the possible cellular mechanisms. In our model, there is always a certain probability that
a virus will be destroyed before it traverses the entirety of the pathway. Our queuing
network models this phenomenon as a virus leaving the network. If a virus successfully
traverses the entirety of the network it arrives in the nucleus, where it leaves the network
by entering the nucleus. The reproduction of viruses in the nucleus cannot easily be
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Figure 6.8: HIV Cellular Pathway Parallel Queuing Network
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modeled as a queue, in fact, this process is similar to a sort of pure-birth process. The
production of viruses is also not memoryless, i.e. production is triggered when a virus
enters the nucleus and ends some time later. For these reasons we have chosen to model
viral reproduction separately from the queuing network, and consider this process to be
a ”Triggered Poisson Process.” We define a Triggered Poisson Process as follows:
The counting process N (t), t ≥ 0, is a Triggered Poisson process with rate λ ≥ 0 if
given a random variable τ such that t < τ
1. N(0) = 0
2. The process has independent increments
3. The number of events in any interval of length t, such that t < τ is Poisson distributed with mean λt. That is ∀ x, s0 ≤ 0 ≤ τ
P( N (t + s) − N (s) = n) = e−λt

(λt)n
n! ,

n = 0, 1, 2, ...

Stated simply, a Triggered Poisson process is a Poisson process which is triggered by
an event (in this case the arrival of a virus) and is terminated after a certain duration of
time has passed (the death of the infected cell).
HIV represents a highly parallel system, that is, there are numerous viruses and numerous T cells that all interact in concert. Our model accounts for this by forming a
parallel set of queuing networks for viruses to infect. Analyzing a set of n identical parallel queues is not a trivial task, to ease this process we have used the splitting property
of the Poisson process to simplify such a parallel network. Consider a queuing network
as shown in Figure 6.7, with Poisson arrival rates nλ1 , ..., nλK for each queue. Then the
Poisson splitting property states that a set of n queues with rates λ1 , ..., λK (see Figure
6.8) is an equivalent queuing network. Thus we can model n parallel queues as a single
queue with arrival rates scaled for n.
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Figure 6.9: HIV Model Overview

In our model there are two states that are shared by each of the parallel queueing
networks; the cell surface and the nucleus. The cell surface is considered the bloodstream
where viruses are free to target and invade T cells, clearly this is a shared state. Although
the nucleus is specific to each T cell, we consider this state as a shared state as well. This
is because we treat the nucleus as a Triggered Poisson Process separate from the queue
where each cell feeds into this shared state. When the nucleus produces additional
viruses these viruses are fed into the shared surface state, forming a feedback loop.
Thus our complete system diagram can be seen in Figure 6.9.

6.4 Analysis of HIV model
In this system we are primarily concerned with the following information: how many
viruses are in a specific state at a given time. Since our model forms an open queuing
network, that is also a Jackson network, we can derive the arrival rate of the jth queue
using equation 6.7. Then using Burke’s theorem we know that this arrival rate is Poisson.
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This means that the mean number of viruses to arrive in a state j at time t is simply λt.
We can further analyze the probability that a queue is in a given state using Jackson’s
theorem, however, we will instead perform a simulation of the model.
The system is then treated as a Poisson process with rate nλnu where nλnu is the arrival rate of a virus to the shared nucleus state and n is the number of parallel queues, or
cells. When a virus arrives in this shared state it creates a new Triggered Poisson process.
While deriving the properties of a Triggered Poisson process is somewhat challenging
creating a simulation is a straightforward process. The results of our simulation can be
found in section 7.2.

6.5 Simulation Model
The highly parallel nature of HIV suggests that one consider a multi-cast communication
network for simulation purposes. In this network, packets are flooded into the channel to
maximize the number of successful transmissions. Once a packet is successfully received,
the receiver begins to copy and forward this information back into the channel. In order
to obtain a pure estimate of the communication efficiency of the virus, we have chosen
simply to model the initial infection phase, where virus growth is uninhibited by external
factors, such as the body’s immune system. Although the current simulation model does
not consider the impact interference would have on communication, it is possible to
integrate this information with our simulation. By forming a model for interference and
including this in the physical layer of the simulation, one would be able to investigate
the impact interference has on the system. We intend to demonstrate this effect once
we have fully studied the initial phase of infection and have formulated a model for
interference.
In order to determine a threshold for various kinetic constants in our simulation
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model, we have used mathematical models for HIV [38][39] as well as models developed
from other viruses, such as adenovirus [54]. While these kinetic constants are not necessarily accurate for HIV, they give us an estimate of a realistic time constants for various
phases of the simulation. At several stages of the model, there are places where a virus
will be routed to another path with a known probability. Fortunately, many biologists
have sought to form models which accurately assess these probabilities [11]. Also, at
several stages of the protocol, there are events which are driven by errors in the system.
We have chosen to model these errors as the result of random noise, and simply generate a random variable to dictate whether an error occurred. This generated error in turn
dictates how a given virus is routed in the pathway.
The basic flow of the simulation is described as follows: A group of viruses is introduced into the channel, where each virus is given an appropriate randomly generated
arrival time and randomly selected target cell to infect. The physical propagation of
the virus in the channel is a complicated process and is currently outside of scope of
this project. Instead of attempting to model this process we simply generate a random
arrival time to simulate the various delay components caused by the channel the virus
must navigate when finding a target cell. Next, the virus will attempt entry into the cell.
Depending on various physical properties of the virus this entry could fail, or choose
a slower path inside the cell. Next the virus must perform reverse transcription, the
process of transcribing its viral RNA into DNA. This process is highly error prone and
has once again been appropriately simulated with noise. Next, the generated DNA must
navigate into the nucleus of the cell, again assuming an appropriate error rate. Assuming this process has completed successfully, the infected cell will now start to replicate
and forward additional viruses into the channel at an appropriate rate. These replicated
viruses then attempt to repeat this entire process infecting more cells. It is simple to see
why the virus grows so rapidly, since it is not atypical for an infected cell to replicate in
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excess of 20 viruses less than 12 hours after becoming infected [9].
The model used for simulation of HIV infection is similar to that of a multi-cast
network, where many packets are delivered into the channel to be accepted by many
receivers. In contrast to a typical multi-cast network, where packets arrive at neighbor nodes deterministically, the arrival of viruses at target cells is typically a random
process. We consider the random arrival of viruses to be similar to multi-casting in a
mobile environment, where autonomous sensor networks (e.g. networks with moving
nodes) are interconnected through wireless channels experiencing fading and randomly
moving in and out of range. Our simulation is concerned specifically with processes
that happen once the packet is received by the local gateway (virus attached to the cell
membrance). In other words, we are only concerned with the activity of this system
from the external gateway to the destination node (cell nucleus). As a result, we will
not attempt to simulate the dynamics of HIV infection in the channel, or its formation
and introduction into the bloodstream. There are many constants required to determine
both the probability for entering certain branches of the HIV pathway, and reasonable
time constraints for each path. There is an enormous body of medical research which
has accurately assessed many of these constants. Since this is such a highly parallelized
system we keep track of information for every virus and every cell at each iteration. Several pieces of information are associated with each virus. For the virus we have the time
to next event (virion event), where the virus is located (virion state), the T cell the virus
has targeted (virion target). For the T cell we have the time to next event (t cell event),
and the production stage of the cell (t cell state). Using this information we may iterate
the simulation at each time-step and simply update the state of each virus and T cell
dependent on the event flag.
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Figure 6.10: Physical Layer Pseudo-Code

Figure 6.11: Network Layer Pseudo-Code

Figure 6.12: Transport Layer Pseudo-Code
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Figure 6.13: Application Layer Pseudo-Code

6.6 Packet Arrival
The dynamics of HIV infection in-vivo can be quite complicated. It is difficult to accurately assess the movement of HIV when it proliferates a system. To account for the
arrival rate of the packets, we simply randomly generate an appropriate arrival time for
each packet and randomly choose a target receiver. It is possible for multiple packets to
be processed by a receiver simultaneously, however, this does not significantly impact
the production rate of the receiver once it enters production mode. It is also possible
that a packet will attempt to navigate to a receiver that has been switched off (destroyed,
and no longer viable to facilitate viral production), at which point the packet will be lost
or resolve itself to a new host. This time delay accounts for the uncertain movements
of the virus at any give time and allows us to realistically simulate these effects without
necessarily knowing or predicting their movements.
The Pareto distribution can model packet delay in a communication network quite
nicely [63]. Although packets arrive at wide intervals of time, most of these arrival times
are clustered close to the origin. The Pareto distribution provides a function for finding such arrival times. The probability density function for an upper-truncated Pareto
random variable, X, has a distribution [1]:
γα ( x −α − ν−α )
p( X > x ) =
α
1 − γν
and density function[1]:

(6.22)
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f x (x) =

αγα x −α−1
α
1 − γν

(6.23)

for the parameters δ, ν, and α being positive reals with γ < ν being the minimum and
maximum values, respectively, and the parameter α defining the shape of the function.

6.7 Receiver Uptake
Once a packet arrives at a target cell it begins to traverse the HIV pathway (see figures
4.1 and 4.2). The HIV pathway contains several junctures or branches where viruses are
routed to a given branch according to some specific physical characteristic. Although
these characteristics are not always well understood by researchers, the probability of a
virus arriving at a particular state has been determined. As a result, at each juncture of
the HIV pathway a random number is chosen which is used to decide where to route the
virus (as dictated by the probability of arrival for each branch). The pseudo-code in Algorithm 6.5 demonstrates how routing during HIV infection is performed; note that this
procedure is called whenever there is a virion event, or in other words, when the virion
has changed states. Additionally, there are several sections of the HIV pathway where
the integrity of the virus is evaluated according to certain physical criteria. This process
differs from routing in that a virus which fails to pass a validation routine may simply
be discarded, and is no longer viable. The pseudo-code in Algorithm 6.5 illustrates this
process. A packet which successfully navigates the entirety of the HIV pathway forces
the receiver to switch into production mode, where it begins to forward copies of the
packet into the channel.
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6.8 Forwarding
Once a receiver (T cell) has been productively infected it begins forwarding additional
copies of the infectious virus back into the channel. Viruses are produced at a constant
rate, and after sufficient time the receiver will produce an additional virus.

6.9 Packet and Receiver Shutdown
The nature of this system warrants that this simulation take the effects of receiver shutdown and packet timeout into account. When a virus productively infects a cell it causes
that cell to produce additional virions. This means that materials within the cell are reconstructed to form additional viruses which are then sent back into the system. This
is similar to when a node forwards a message back into a channel, in this case however,
the node can still accept incoming messages and forward additional copies. After a sufficient amount of time the infected cell will be destroyed by the virus, at this point the
cell is simply eliminated from the simulation.

6.10

Virus Destruction

At any stage of the simulation there is a probability that a virus will simply decay or
be eliminated by the human immune system. While antibodies which fight HIV are not
in sufficient quantities during the initial stage of infection [36], there is a chance a virus
may be eliminated in this manner. Additionally, a virus which fails to internalize into a
T cell host has a much higher chance of becoming destroyed. To account for this each
virus has a timeout which is randomly selected. If the timeout exceeds the amount of
time the virus propagates the channel, then it is destroyed.
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6.11

Simulation Parameters

The following section describes the parameters used for our HIV simulation. Finding
accurate measurements for these kinetic properties is not an easy task, in fact many of
these constants are derived from different viruses and other mathematical models. It is
likely that some of these constants are inaccurate, perhaps as much as an order of magnitude, however, we have found discrepancies and variation among numerous sources
for given constants. In the future, we would welcome HIV experts to correct these discrepancies as we feel this is the primary reason for the scale discrepancy between our
simulation results and measured HIV infection.
T cell Virus Production Rate

10-100 Viruses/day [9][20]

Infected T cell lifespan

2.2 days [38]

Virus plasma lifespan

7.2 hours [38]

Dissociation rate
Surface to Cytoplasm (Fusion)
Surface to Endosome (Endocytosis)
Endosome to Cytoplasm
Cytoplasm to Reverse Transcription
Reverse Transcription to Nucleus

0.001-.01 Viruses/hour (0.003 average) [26]
0.001-0.01 Viruses/min [11]
0.003 Viruses/min [11]
0.001-0.02 (based on PEG study) Viruses/min [30]
0.001-0.033 Viruses/min [21]
.17 - .25 Viruses/hour [53]
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Chapter 7
Results
We have extracted the following results from our mathematical model and simulation of
HIV proliferation (Figures 7.1 and 7.2). Due to the computational intensity of the simulation, we have restricted the total number of receivers (T cells) present in the system.
All results were generated with a set of 103 —106 T cells. While this does not realistically reflect the typical number of T cells in the human body, it allows simulations to
be performed in a reasonable time span. Currently, simulated events are happening too
quickly or in the incorrect time span as compared against actual measured HIV proliferation rates [4][24](a time-scale of approximately 30% for the simulation and a time shift
of approximately 6 days for the mathematical model), see Figure 7.3. However, when
accounting for this time-scale and adjusting appropriately one can see the simulated
events align with actual measured viral growth[4][24] quite well (see figure 7.4). It is
also visible that the quantity of viruses aligns very well with measured data without any
alteration, which is quite impressive.
The simulation model is easily adjustable and may be used to experiment with the
effect various simulation constants have on communication efficacy. The results of our
simulations indicate that changing constants, even slightly, can have a distinct and often
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Figure 7.1: HIV Model Results

Figure 7.2: Simulation Results for 1,000,000 T cells

15

72

4

3

Comparison of Simulation, Mathematical Model, and Measured HIV Viral Copies

x 10

Virions per mm3 plasma

2.5

2

1.5

1

Mathematical Model

0.5

Simulation
Measured Data
0

0

2

4

6

8

10
Time (Days)

12

14

16

18

20
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Figure 7.4: Scaled Comparison of Simulation, Model, and Measured data [4][24]

drastic impact on the results. However, despite the sensitivity of certain constants in the
simulation the general shape of growth stays somewhat constant. This clearly indicates
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that there are parameters for communication which are more critical for successful proliferation than others. Although we have encountered a time-scale discrepancy when
applying our model to HIV proliferation, we feel the simulation model works quite well
as the reason for said discrepancy is likely due to inaccurate simulation constants.
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Chapter 8
Conclusion
Telecommunications models can be applied to HIV infection and this model accurately
abstracts the intricate processes involved with HIV communication. The novelty of this
model is that it has been used to successfully model and abstract a biological process
into a communication network. The preliminary results of our mathematical model and
simulation demonstrate that our model is quite capable of predicting the shape of growth
for the proliferation of HIV during the initial phase of infection. The simulation model
may be easily adjusted and may be used to experiment with the communication aspects
of HIV proliferation. The flexibility of the model demonstrates that it may currently be
used to model and simulate viruses which are similar to HIV. In the future we hope to
enhance the accuracy of the simulation and begin to evaluate other forms of biological
communication.
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